Avid Bioservices Inc (CDMO)

[BioBS2012]

Contrary to many statements made on this board, I/O trials and combo assessments (positive/negative and discernible trajectory) are now achieved in months and in many cases within trial groups of 2 dozen or less.

All the more reason to expect some data from the ongoing melanoma IST before the end of 2015 !!!

Cheers.